Nasopharyngitis.
Horiguti S.
Acta Otolaryngol Suppl. 1975;329:1-120.
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials.
Danese S, Vermeire S, Zhou W, Pangan AL, Siffledeen J, Greenbloom S, Hébuterne X, D'Haens G, Nakase H, Panés J, Higgins PDR, Juillerat P, Lindsay JO, Loftus EV Jr, Sandborn WJ, Reinisch W, Chen MH, Sanchez Gonzalez Y, Huang B, Xie W, Liu J, Weinreich MA, Panaccione R.
Lancet. 2022 Jun 4;399(10341):2113-2128. doi: 10.1016/S0140-6736(22)00581-5. Epub 2022 May 26.
Acute Herpetic Nasopharyngitis in an Adult Patient: A Case Report and Literature Review.
Kuo CC, Piccillo EM, DeGiovanni JC, Kabalan M, Zimmer G, Carr MM.
Ann Otol Rhinol Laryngol. 2022 Dec;131(12):1390-1393. doi: 10.1177/00034894211070138. Epub 2022 Jan 6.
Tofacitinib for the treatment of psoriasis and psoriatic arthritis.
Berekmeri A, Mahmood F, Wittmann M, Helliwell P.
Expert Rev Clin Immunol. 2018 Sep;14(9):719-730. doi: 10.1080/1744666X.2018.1512404.
Successful management of nasopharyngitis caused by Schizophyllum commune in a captive cheetah (Acinonyx jubatus).
Noguchi S, Toyota K, Ozaki M, Wada Y, Takami Y, Tanaka M, Kuwamura M, Shimada T.
J Vet Med Sci. 2023 Oct 17;85(10):1074-1076. doi: 10.1292/jvms.23-0273. Epub 2023 Aug 11.
Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy.
Napolitano M, D'Amico F, Ragaini E, Peyrin-Biroulet L, Danese S.
Drug Des Devel Ther. 2022 Jun 17;16:1897-1913. doi: 10.2147/DDDT.S340459. eCollection 2022.
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.
Reich K, Kabashima K, Peris K, Silverberg JI, Eichenfield LF, Bieber T, Kaszuba A, Kolodsick J, Yang FE, Gamalo M, Brinker DR, DeLozier AM, Janes JM, Nunes FP, Thyssen JP, Simpson EL.
JAMA Dermatol. 2020 Dec 1;156(12):1333-1343. doi: 10.1001/jamadermatol.2020.3260.
Purulent nasal discharge due to gonococcal nasopharyngitis in a neonate.
Inaba S, Aizawa Y, Kataoka S, Saitoh A.
J Infect Chemother. 2023 Dec;29(12):1164-1166. doi: 10.1016/j.jiac.2023.08.005. Epub 2023 Aug 7.
Microbial dynamics of purulent nasopharyngitis in children.
Brook I.
Int J Pediatr Otorhinolaryngol. 2003 Oct;67(10):1047-53. doi: 10.1016/s0165-5876(03)00203-9.
[Acute nasopharyngitis].
Sedlácek K.
Zdrav Aktual. 1983;204:59-62.
